ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

MEDS TRxADE HEALTH Inc

6,29
0,28 (4,66%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
TRxADE HEALTH Inc MEDS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,28 4,66% 6,29 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,02 6,02 6,42 6,29 6,01
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202422:05GLOBETRxADE Health, Inc. Announces Receipt of Notice from Nasdaq..
06/3/202414:30EDGAR2Form 8-K - Current report
06/3/202414:05GLOBETRxADE Health, Inc. Announces Special Cash Dividend
26/2/202418:00EDGAR2Form SEC STAFF ACTION - SEC Staff Action: ORDER
16/2/202423:05EDGAR2Form 8-K - Current report
14/2/202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202415:07GLOBETrxade health, Inc files its 3Q 10Q
17/1/202415:05EDGAR2Form 8-K - Current report
16/1/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/1/202412:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:25EDGAR2Form 8-K - Current report
30/11/202300:13GLOBETRxADE Announces Receipt of Notification of Deficiency from..
28/11/202318:29EDGAR2Form 8-K - Current report
15/11/202319:51EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
17/10/202314:05GLOBETrxADE Health, Inc. affirms its commitment to the..
13/10/202319:25EDGAR2Form 8-K - Current report
12/10/202314:05GLOBESuperlatus Announces Distribution Partnership with North..
11/10/202322:05EDGAR2Form 8-K - Current report
04/10/202315:29EDGAR2Form 8-K - Current report
04/10/202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Acquires the..
25/9/202314:06EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/9/202323:28EDGAR2Form 8-K - Current report
08/9/202316:42EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07/9/202314:05GLOBESuperlatus Announces Planned Expansion into Pet Food Market
25/8/202312:15EDGAR2Form 8-K - Current report
24/8/202315:47EDGAR2Form 8-K - Current report
24/8/202314:05GLOBESuperlatus Innovates $151 Billion US Snacking Market with..
22/8/202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Agrees to..
18/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202316:25GLOBETRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14/8/202314:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/8/202312:20EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202315:05GLOBENewly merged Entity Superlatus, Inc with Trxade Health, Inc...
31/7/202315:40EDGAR2Form 8-K - Current report
31/7/202314:35GLOBETRxADE HEALTH, Inc. Announces Closing of Acquisition of..
14/7/202323:08EDGAR2Form 425 - Prospectuses and communications, business..
14/7/202323:07EDGAR2Form 8-K - Current report
14/7/202322:30GLOBETRxADE HEALTH, Inc. Amends Definitive Merger Agreement with..
10/7/202322:58EDGAR2Form 8-K - Current report
30/6/202315:25EDGAR2Form 425 - Prospectuses and communications, business..
30/6/202315:25EDGAR2Form 8-K - Current report
30/6/202314:05GLOBESuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive..
27/6/202314:00GLOBESuperlatus, Inc. Announces New Appointments to the..
23/6/202322:40GLOBETRxADE HEALTH, Inc. Issues Correction to Press Release..
23/6/202314:05GLOBESuperlatus, Inc. to Combine with TRxADE HEALTH, Inc., to..
21/6/202318:36GLOBETRxADE Health, Inc.’s Board of Directors Approves Reverse..
15/5/202322:15GLOBETRxADE HEALTH Reports First Quarter Gross Margin of 69% and..

Dernières Valeurs Consultées

Delayed Upgrade Clock